![](/img/cover-not-exists.png)
A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney Disease
Sabounjian, LuAnn, Graham, Philip, Wu, Lijun, Braman, Virginia, Cheng, Changfu, Liu, Julie, Shipley, James, Neutel, Joel, Dao, MichaelVolume:
5
Language:
english
Journal:
Clinical Pharmacology in Drug Development
DOI:
10.1002/cpdd.241
Date:
July, 2016
File:
PDF, 701 KB
english, 2016